During the past decade, Clinique Alleray-Labrouste conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinique Alleray-Labrouste" are "Acute Coronary Syndrome" (1 trials), "Lesion" (1 trials), "Silent Myocardial Infarction" (1 trials) and "Stable Angina" (1 trials). Many other conditions were trialed in "Clinique Alleray-Labrouste" in a lesser frequency.

Most popular intervention types in "Clinique Alleray-Labrouste" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cobalt-Chromium Bare Metal Stents" (1 trials), "PTCA with stent implantation" (1 trials) and "Titan 2 stents" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Alleray-Labrouste" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinique Alleray-Labrouste". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinique Alleray-Labrouste, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Alleray-Labrouste, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".